Pharma Aids Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	474.48	438.09	421.23	308.49	323.05	280.29
Revenue Growth (YoY)	9.96%	4.00%	36.55%	-4.50%	15.25%	3.98%
Cost of Revenue	327.71	306.09	291.88	257.2	219.58	174.95
Gross Profit	146.77	131.99	129.36	51.29	103.47	105.34
Selling, General & Admin	47.59	45.49	44.03	37.32	45.63	38.17
Other Operating Expenses	0.01	0.14	0.07	2.21	1.94	0.07
Operating Expenses	50.54	48.58	44.99	40.63	49.45	39.02
Operating Income	96.24	83.41	84.36	10.66	54.02	66.33
Interest Expense	-2.44	-1.75	-0.26	-0.24	-0.38	-0.9
Interest & Investment Income	0.24	0.36	0.62	-	-	-
Other Non Operating Income (Expenses)	-0.11	-0.07	-0.16	-0.13	-0.09	-0.07
EBT Excluding Unusual Items	93.93	81.96	84.56	10.3	53.54	65.35
Gain (Loss) on Sale of Assets	-	0.37	-	-	-	-
Pretax Income	93.93	82.32	84.56	10.3	53.54	65.35
Income Tax Expense	21.47	18.51	23.38	16.68	18.78	15.1
Net Income	72.46	63.82	61.19	-6.38	34.76	50.26
Net Income to Common	72.46	63.82	61.19	-6.38	34.76	50.26
Net Income Growth	15.97%	4.30%	-	-	-30.83%	-4.22%
Shares Outstanding (Basic)	3	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3	3
EPS (Basic)	23.23	20.45	19.61	-2.05	11.14	16.11
EPS (Diluted)	23.23	20.45	19.61	-2.05	11.14	16.11
EPS Growth	15.97%	4.30%	-	-	-30.83%	-4.22%
Free Cash Flow	-0.89	-17.37	22.6	5.06	29.15	21.12
Free Cash Flow Per Share	-0.29	-5.57	7.25	1.62	9.34	6.77
Dividend Per Share	3.000	3.000	2.500	1.000	5.000	5.000
Dividend Growth	20.00%	20.00%	150.00%	-80.00%	-	-
Gross Margin	30.93%	30.13%	30.71%	16.63%	32.03%	37.58%
Operating Margin	20.28%	19.04%	20.03%	3.46%	16.72%	23.66%
Profit Margin	15.27%	14.57%	14.53%	-2.07%	10.76%	17.93%
Free Cash Flow Margin	-0.19%	-3.97%	5.37%	1.64%	9.02%	7.54%
EBITDA	104.53	89.91	91.28	18.29	61.84	74.58
EBITDA Margin	22.03%	20.52%	21.67%	5.93%	19.14%	26.61%
D&A For EBITDA	8.29	6.5	6.92	7.62	7.82	8.25
EBIT	96.24	83.41	84.36	10.66	54.02	66.33
EBIT Margin	20.28%	19.04%	20.03%	3.46%	16.72%	23.66%
Effective Tax Rate	22.86%	22.48%	27.64%	161.99%	35.07%	23.10%
Advertising Expenses	-	0.61	0.75	0.89	0.97	0.96

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.